Literature DB >> 21231898

SLC40A1 Q248H allele frequencies and associated SLC40A1 haplotypes in three West African population samples.

David Albuquerque1, Licínio Manco, Kovana M Loua, Ana Paula Arez, Maria de Jesus Trovoada, Luís Relvas, Tamba S Millimono, Silvia L Rath, Dinora Lopes, Fátima Nogueira, Luís Varandas, Manuela Alvarez, M Letícia Ribeiro.   

Abstract

BACKGROUND: Ferroportin is a transmembrane protein responsible for iron export from enterocytes and macrophages. Mutation c.744G → T (Q248H), located in exon 6 of the ferroportin gene SLC40A1, is found as a polymorphism in populations of African origin. This mutation has been extensively analysed in African-Americans, but poorly studied in native African populations. AIM: To increase information about Q248H mutation frequency in native sub-Saharan populations examining three West African populations. SUBJECTS AND METHODS: Samples from S. Tomé e Príncipe (n = 115), Angola (n = 156) and Republic of Guinea (n = 170) were analysed for Q248H mutation and for two polymorphisms, IVS1( - 24)G → C and microsatellite (CGG)(n), using standard molecular methodology.
RESULTS: The estimated frequencies of Q248H allele were 2.2% in S. Tomé e Príncipe, 3.5% in Angola and 4.1% in Republic of Guinea. Analysis of polymorphisms IVS1( - 24)G → C and (CGG)(n) showed mutation allele c.744T to be strongly associated with haplotype IVS1( - 24)G/(CGG)(7).
CONCLUSIONS: This study confirmed the presence of Q248H mutation at polymorphic frequencies in three native sub-Saharan populations. Analysis of two additional markers in the same gene support a single origin of the mutant allele c.744T in the haplotype background IVS1( - 24)G/(CGG)(7).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21231898     DOI: 10.3109/03014460.2010.541496

Source DB:  PubMed          Journal:  Ann Hum Biol        ISSN: 0301-4460            Impact factor:   1.533


  5 in total

1.  Erythrocytic ferroportin reduces intracellular iron accumulation, hemolysis, and malaria risk.

Authors:  De-Liang Zhang; Jian Wu; Binal N Shah; Katja C Greutélaers; Manik C Ghosh; Hayden Ollivierre; Xin-Zhuan Su; Philip E Thuma; George Bedu-Addo; Frank P Mockenhaupt; Victor R Gordeuk; Tracey A Rouault
Journal:  Science       Date:  2018-03-30       Impact factor: 47.728

2.  Reduced sensitivity of the ferroportin Q248H mutant to physiological concentrations of hepcidin.

Authors:  Sergei Nekhai; Min Xu; Altreisha Foster; Ishmael Kasvosve; Sharmin Diaz; Roberto F Machado; Oswaldo L Castro; Gregory J Kato; James G Taylor; Victor R Gordeuk
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

Review 3.  Ethnic Differences in Iron Status.

Authors:  Wanhui Kang; Alexa Barad; Andrew G Clark; Yiqin Wang; Xu Lin; Zhenglong Gu; Kimberly O O'Brien
Journal:  Adv Nutr       Date:  2021-10-01       Impact factor: 8.701

4.  Ferroportin Q248H mutation was not found to be protective against malaria and anemia in children under 5 years living in South Kivu/Democratic Republic of Congo, an endemic area of P lasmodium infection.

Authors:  Yvette Lufungulo Bahati; Joris Delanghe; Ghislain Bisimwa Balaluka; Karl Vandepoele; Justin Cikomola Cirhuza; Antoine Sadiki Kishabongo; Jan Philippé
Journal:  Heliyon       Date:  2022-08-28

Review 5.  Twenty Years of Ferroportin Disease: A Review or An Update of Published Clinical, Biochemical, Molecular, and Functional Features.

Authors:  L Tom Vlasveld; Roel Janssen; Edouard Bardou-Jacquet; Hanka Venselaar; Houda Hamdi-Roze; Hal Drakesmith; Dorine W Swinkels
Journal:  Pharmaceuticals (Basel)       Date:  2019-09-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.